from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1932/tpx

LFCtreatmentdescriptionclass of inhibitor

0.590

Amikacinug/mL Amikacintranslation

0.836

Cap5-10ug/mL Capreomycintranslation

-0.707

Rox10-50 ug/mL Roxithromycintranslation

0.719

SM2-5 ug/mL Streptomycintranslation

0.755

Tet5-10 ug/mL Tetracyclinetranslation

0.424

Rif0.2-5ug/mL Rifampicintranscription

-0.063

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.308

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.538

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.672

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.841

Clofazimine10-13 ug/mL Clofaziminerespiration

0.408

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-2.084

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.466

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.201

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.329

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.768

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.918

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.078

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.020

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.412

KCN5-20 ug/mL Potassium cyaniderespiration

0.693

NaN30.2-2 mM Sodium aziderespiration

0.260

Nigericin50 uM Nigericinrespiration

-0.053

TRC10-150 ug/mL Triclosanrespiration

-1.765

TRZ10-25 ug/mL Thioridazinerespiration

-1.435

Valinomycin0.5-10 uM Valinomycinrespiration

0.947

ZnSO42 mM ZnSO4respiration

-0.357

menadione6-10 ug/mL Menadionerespiration

-0.813

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.759

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.178

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.754

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.181

NRP_1Non-replicating persistence stage 1dosRassociated

0.811

Amp0.2mg/mL AmpicillincellWall

0.742

Cephalexin20-100 ug/mL CephalexincellWall

0.215

Cerulenin0.32-5 ug/mL CerulenincellWall

0.835

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.161

EMB10-20 ug/mL EthambutolcellWall

1.147

Eta12-40 ug/mL EthionamidecellWall

1.521

INH0.2-0.4 ug/mL IsoniazidcellWall

0.601

TLM0.1-0.2 mg/mL ThiolactomycincellWall

0.677

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.555

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.000

BZA0.12 mg/mL BenzamidearomaticAmides

0.000

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.000

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.000

H2O24 mM hydrogen peroxideDNAdamaging

0.127

Levo10 ug/mL LevofloxacinDNAdamaging

0.000

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.921

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.791

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.000

UVUV-irradiationDNAdamaging

-1.154

ARP41-4 ug/mL Antitubercular compound ARP4?

0.386

Antimycin12.5-50 ug/mL Antimycin A?

0.261

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.908

PA_110-50 ug/mL Antitubercular compound PA-1?

0.806

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.924

PA8240.2-2 ug/mL PA-824?

0.077

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.794

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.050

Verapamil50 uM Verapamil?

0.960

mercaptoethanol2 mM 2-Mercaptoethanol?

0.117

methoxatin10-20 ug/mL Methoxatin?